This message was sent to ##Email##
The application deadline is January 7, 2018.
The National Council of the AFMR invites you to apply for the following AFMR National Awards. Recipients will present their work during an oral session at the 2018 Translational Science meeting to be held April 19-21, 2018 in Washington, DC.
Lipid Metabolism and Treatment: New Insights from Childhood to Adulthood
Siham Accacha, MD, NYU Winthrop Hospital, Mineola NY
9th Annual Former AFMR/AFCR President’s Address
J. Sanford Schwartz, MD
University of Pennsylvania, Wharton School, Philadelphia PA
Professor of Medicine, Health Care Management and Economics
FASEB sent a letter to the House and Senate leaders urging them to reach an agreement to raise the Budget Control Act spending caps as soon as possiblle. FASEB's letter noted that science requires sustained support to produce new knowledge and innovations. The current caps are so low that they short change funding for critical priorities including biomedical and biological research supported by the National Institutes of Health (NIH), National Science Foundation (NSF), and other agencies.
Click here for the winners of the 2017 BioArt Contest.
Collaborate with the leading scientists on emerging and cutting-edge research and topics in your field.
FASEB’s Scientific Research Conferences connect experts and early career professionals in collaborative/interactive environments packed with lectures, posters sessions, career workshops, and networking.
Click on the 2018 conferences below to learn about program highlight and add the event dates to your calendar. Registration will open on Thursday, January 11, 2018!
FASEB seeks applications for the position of Editor-in-Chief (EIC). The EIC position will be for a new open access journal. The ideal candidate will be a distinguished scientist with a Ph.D., M.D., or an equivalent academic degree, experience in experimental biological and biomedical sciences, and prior experience in editorial activities related to scholarly journals. The initial term will be three years, but may be renewed if mutually agreed by FASEB and the selected candidate. The EIC will have responsibility for establishing editorial workflows and selecting supporting editors and an editorial board. It is a volunteer position that reports to FASEB’s Board of Directors through the FASEB Publications and Communications Committee. The position will remain open until a suitable candidate has been identified and the vacancy filled.
Cytokeratin-18 and enhanced liver fibrosis scores in type 1 and type 2 diabetes and effects of two different insulins
Arun Sanyal, Kenneth Cusi, Mark L Hartman, Shuyu Zhang, Edward J Bastyr, Juliana M Bue-Valleskey, Annette M Chang, Axel Haupt, Scott J Jacober, Robert J Konrad, Qianyi Zhang, Byron J Hoogwerf
Journal of Investigative Medicine Nov 2017, jim-2017-000609; DOI: 10.1136/jim-2017-000609
Impact of weight loss on inflammation and red blood cell biomarkers after laparoscopic gastric banding surgery
Susana Coimbra, Cátia Ferreira, Luís Belo, Petronila Rocha-Pereira, Alice Catarino, Luís Monteiro, Cristina Catarino, AliceSantos-Silva
Journal of Investigative Medicine Nov 2017, jim-2017-000528; DOI: 10.1136/jim-2017-000528
Microtubules-associated Rac regulation of endothelial barrier: a role of Asef in acute lung injury
Pratap Karki, Anna A Birukova
November 23, 65 (8) 1089-1092; DOI: 10.1136/jim-2017-000571
Wnt signaling and podocyte dysfunction in diabetic nephropathy
Madhura Bose, Sadia Almas, Sharma Prabhakar
November 23, 65 (8) 1093-1101; DOI: 10.1136/jim-2017-000456
Influence of dietary macronutrients on liver fat accumulation and metabolism
Siôn A Parry, Leanne Hodson
November 23, 65 (8) 1102-1115; DOI: 10.1136/jim-2017-000524
Acute Kidney Injury, Immune Thrombocytopenic Purpura, and the Infection That Binds Them Together: Disseminated Histoplasmosis
Michael McPhaul, MD,
Untreated human immunodeficiency virus (HIV) can be complicated by opportunistic infections, including disseminated histoplasmosis (DH). Although endemic to portions of the United States and usually benign, DH can rarely act as an opportunistic infection in immunocompromised patients presenting with uncommon complications such as acute kidney injury and idiopathic thrombocytopenic purpura. We report a rare presentation of DH presenting with acute kidney injury and immune thrombocytopenic purpura in an immunocompromised patient with HIV. READ MORE
A Challenging Case of Pseudohyperkalemia in Chronic Lymphocytic Leukemia
Pseudohyperkalemia is an uncommon finding in chronic lymphocytic leukemia. It is a misleading condition that could lead to iatrogenic hypokalemia when unwarranted treatment is administered. We describe an interesting case of pseudohyperkalemia in severe leukocytosis and how we identified it. READ MORE
Use of Tachycardia in Patients With Submassive Pulmonary Emboli to Risk Stratify for Early Initiation of Thrombolytic Therapy: A Case Series Comparing Early Versus Late Thrombolytic Initiation
Pulmonary embolism (PE) represents a prevalent cause of morbidity and mortality in the United States, with approximately 600 000 cases diagnosed annually. The mortality rate for untreated PE is as high as 30%. Right ventricular (RV) dysfunction is a sign of possible adverse outcomes with right-sided heart failure being the usual cause of death from PE. There is a spectrum of clinical presentations associated with PE diagnoses, from incidental and asymptomatic to rapid hemodynamic collapse. Despite successes in identifying patients with “high-risk” PEs for aggressive thrombolytic interventions and “low-risk” PEs for outpatient anticoagulation, a significant lack of consensus exists regarding intervention modalities for PEs identified as “intermediate risk” or “submassive,” defined as normotensive (systolic blood pressure ≥90 mm Hg) with acute RV dysfunction and myocardial injury. In this case series, we review the management and outcomes of 2 patients with submassive PEs and sustained tachycardia in the setting of normal blood pressures, and we address the need to recognize tachycardia as an ominous RV compensatory sign, indicative of impending hemodynamic collapse, that should lead to aggressive therapy with vascular intervention. READ MORE
Stay informed about JIM-HICR and register for e-alerts.
A bivalent meningococcal B vaccine targeting factor H-binding protein (MenB-FHbp) elicits bactericidal responses against diverse meningococcal B strains after two and three doses in adolescents and young adults, according to a study published in the Dec. 14 issue of the New England Journal of Medicine.
Takotsubo cardiomyopathy is associated with long-term symptomatic and functional impairment due to subclinical cardiac dysfunction, according to results from the HEROIC study.
Although there is a rapid recovery of left ventricular ejection fraction after takotsubo cardiomyopathy, it was not known whether the condition conferred long-term clinical and functional consequences, the researchers wrote in the study background.
A recently published study showed that patients with chronic hepatitis C have an increased risk for chronic kidney disease. Additionally, HCV treatment appeared to improve survival among patients with chronic HCV and patients on hemodialysis compared with untreated patients.
Ablation for ventricular tachycardia may be achieved by noninvasive means with cardiac radiation, a case series showed.
The catheter-free radioablation technique used by Phillip Cuculich, MD, of Washington University School of Medicine in St. Louis, and colleagues resulted in a 99.9 percent reduction of ventricular tachycardia episodes among five study subjects, as recorded by implantable cardioverter-defibrillators (ICDs).
|January 25-27, 2018
||Western Medical Research Conference
|February 22-24, 2018
||Southern Regional Meeting
||New Orleans, LA
|March 16, 2018
||Eastern Regional Meeting
|April 19-21, 2018
||Translational Science 2018
|April 21-25, 2018
|| Experimental Biology 2018
||San Diego, CA
|April 26-27, 2018
||2018 Combined Annual Meeting of CSCTR & MWAFMR
| || |
Connect with AFMR
Recent Issues | Subscribe | Unsubscribe | Advertise | Web Version
Colby Horton, Vice President of Publishing, 469-420-2601 | Download media kit
Natalie Thomas, Assistant Executive Editor, 469-420-2635 | Contribute news
MingMing Ning, AFMR Chair, Publishing Committee, 978-927-8330 | www.afmr.org
Elissa Klein, AFMR Executive Director, 978-927-8330 | www.afmr.org
American Federation for Medical Research
500 Cummings Center, Suite 4400 | Beverly, MA 01915 | 978-927-8330 | Contact Us
Learn how to add us to your safe sender list so our emails get to your inbox.
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063